View ValuationMortech 将来の成長Future 基準チェック /06現在、 Mortechの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長51.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • Apr 08Full year 2025 earnings released: NT$0.84 loss per share (vs NT$0.74 loss in FY 2024)Full year 2025 results: NT$0.84 loss per share (further deteriorated from NT$0.74 loss in FY 2024). Revenue: NT$81.9m (up 7.2% from FY 2024). Net loss: NT$33.7m (loss widened 14% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 153% per year, which means it is well ahead of earnings.お知らせ • Mar 20Mortech Corporation, Annual General Meeting, Jun 23, 2026Mortech Corporation, Annual General Meeting, Jun 23, 2026. Location: no,2-6, kung yeh 2nd rd., pingjhen district, taoyuan city TaiwanNew Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 20% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Revenue is less than US$5m (NT$93m revenue, or US$2.9m). Market cap is less than US$100m (NT$1.56b market cap, or US$49.6m).New Risk • Apr 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: NT$296.0m (US$8.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (NT$296.0m market cap, or US$8.95m). Minor Risk Revenue is less than US$5m (NT$76m revenue, or US$2.3m).Reported Earnings • Mar 30Full year 2024 earnings released: NT$0.74 loss per share (vs NT$1.48 loss in FY 2023)Full year 2024 results: NT$0.74 loss per share (improved from NT$1.48 loss in FY 2023). Revenue: NT$76.4m (up 48% from FY 2023). Net loss: NT$29.6m (loss narrowed 50% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.お知らせ • Mar 21Mortech Corporation, Annual General Meeting, Jun 23, 2025Mortech Corporation, Annual General Meeting, Jun 23, 2025. Location: no,2-6, kung yeh 2nd rd., pingjhen district, taoyuan city TaiwanNew Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$410.0m market cap, or US$12.5m).New Risk • Feb 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$452.0m market cap, or US$13.8m).New Risk • Aug 18New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$552.0m market cap, or US$17.1m).Reported Earnings • Apr 03Full year 2023 earnings released: NT$1.48 loss per share (vs NT$0.038 profit in FY 2022)Full year 2023 results: NT$1.48 loss per share (down from NT$0.038 profit in FY 2022). Revenue: NT$51.7m (down 54% from FY 2022). Net loss: NT$59.2m (down NT$60.7m from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 13% per year.お知らせ • Mar 24Mortech Corporation, Annual General Meeting, Jun 13, 2024Mortech Corporation, Annual General Meeting, Jun 13, 2024.New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.4% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (NT$102m revenue, or US$3.2m). Market cap is less than US$100m (NT$370.4m market cap, or US$11.7m).New Risk • Oct 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.8% average weekly change). Revenue is less than US$5m (NT$102m revenue, or US$3.2m). Market cap is less than US$100m (NT$396.0m market cap, or US$12.2m).Reported Earnings • Apr 21Full year 2022 earnings released: EPS: NT$0.04 (vs NT$0.72 loss in FY 2021)Full year 2022 results: EPS: NT$0.04 (up from NT$0.72 loss in FY 2021). Revenue: NT$111.2m (flat on FY 2021). Net income: NT$1.53m (up NT$30.4m from FY 2021). Profit margin: 1.4% (up from net loss in FY 2021). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 05Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: NT$0.72 loss per share (down from NT$0.45 loss in FY 2020). Revenue: NT$110.6m (up 29% from FY 2020). Net loss: NT$28.9m (loss widened 62% from FY 2020). Revenue was in line with analyst estimates.Reported Earnings • Aug 09First half 2021 earnings released: NT$0.46 loss per share (vs NT$0.09 loss in 1H 2020)The company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: NT$55.1m (up 2.2% from 1H 2020). Net loss: NT$18.3m (loss widened 411% from 1H 2020).Reported Earnings • Apr 02Full year 2020 earnings released: NT$0.45 loss per share (vs NT$0.50 loss in FY 2019)The company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: NT$85.7m (down 15% from FY 2019). Net loss: NT$17.9m (loss narrowed 4.9% from FY 2019).分析記事 • Mar 25Mortech (GTSM:7419) Is In A Strong Position To Grow Its BusinessEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Is New 90 Day High Low • Jan 27New 90-day low: NT$14.70The company is down 17% from its price of NT$17.70 on 30 October 2020. The Taiwanese market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.分析記事 • Dec 10Companies Like Mortech (GTSM:7419) Can Afford To Invest In GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Is New 90 Day High Low • Oct 29New 90-day low: NT$17.30The company is down 4.0% from its price of NT$18.00 on 31 July 2020. The Taiwanese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Mortech は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TPEX:7419 - アナリストの将来予測と過去の財務データ ( )TWD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202582-34-17-14N/A9/30/202587-32-14-11N/A6/30/202593-30-12-8N/A3/31/202584-30-17-13N/A12/31/202476-30-21-18N/A9/30/202460-42-36-34N/A6/30/202444-55-50-49N/A3/31/202448-57-38-37N/A12/31/202352-59-26-25N/A9/30/202377-36-12-11N/A6/30/2023102-1423N/A3/31/2023107-6711N/A12/31/202211121218N/A9/30/2022105-7412N/A6/30/202298-16-47N/A3/31/2022104-22-23-12N/A12/31/2021111-29-41-32N/A9/30/202199-31-42-34N/A6/30/202187-33-43-36N/A3/31/202186-25-31-22N/A12/31/202086-18-20-9N/A9/30/202096-13-101N/A6/30/2020106-8011N/A3/31/2020103-14310N/A12/31/2019100-19610N/A9/30/201997-28N/A4N/A6/30/201994-38N/A-2N/A3/31/201988-34N/A-3N/A12/31/201882-31N/A-4N/A12/31/20179617N/A13N/A12/31/20167211N/A27N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 7419の予測収益成長が 貯蓄率 ( 1.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 7419の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 7419の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 7419の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 7419の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 7419の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/18 12:06終値2026/05/18 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Mortech Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Apr 08Full year 2025 earnings released: NT$0.84 loss per share (vs NT$0.74 loss in FY 2024)Full year 2025 results: NT$0.84 loss per share (further deteriorated from NT$0.74 loss in FY 2024). Revenue: NT$81.9m (up 7.2% from FY 2024). Net loss: NT$33.7m (loss widened 14% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 153% per year, which means it is well ahead of earnings.
お知らせ • Mar 20Mortech Corporation, Annual General Meeting, Jun 23, 2026Mortech Corporation, Annual General Meeting, Jun 23, 2026. Location: no,2-6, kung yeh 2nd rd., pingjhen district, taoyuan city Taiwan
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 20% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Revenue is less than US$5m (NT$93m revenue, or US$2.9m). Market cap is less than US$100m (NT$1.56b market cap, or US$49.6m).
New Risk • Apr 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: NT$296.0m (US$8.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (NT$296.0m market cap, or US$8.95m). Minor Risk Revenue is less than US$5m (NT$76m revenue, or US$2.3m).
Reported Earnings • Mar 30Full year 2024 earnings released: NT$0.74 loss per share (vs NT$1.48 loss in FY 2023)Full year 2024 results: NT$0.74 loss per share (improved from NT$1.48 loss in FY 2023). Revenue: NT$76.4m (up 48% from FY 2023). Net loss: NT$29.6m (loss narrowed 50% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 21Mortech Corporation, Annual General Meeting, Jun 23, 2025Mortech Corporation, Annual General Meeting, Jun 23, 2025. Location: no,2-6, kung yeh 2nd rd., pingjhen district, taoyuan city Taiwan
New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$410.0m market cap, or US$12.5m).
New Risk • Feb 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$452.0m market cap, or US$13.8m).
New Risk • Aug 18New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$552.0m market cap, or US$17.1m).
Reported Earnings • Apr 03Full year 2023 earnings released: NT$1.48 loss per share (vs NT$0.038 profit in FY 2022)Full year 2023 results: NT$1.48 loss per share (down from NT$0.038 profit in FY 2022). Revenue: NT$51.7m (down 54% from FY 2022). Net loss: NT$59.2m (down NT$60.7m from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 13% per year.
お知らせ • Mar 24Mortech Corporation, Annual General Meeting, Jun 13, 2024Mortech Corporation, Annual General Meeting, Jun 13, 2024.
New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.4% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (NT$102m revenue, or US$3.2m). Market cap is less than US$100m (NT$370.4m market cap, or US$11.7m).
New Risk • Oct 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.8% average weekly change). Revenue is less than US$5m (NT$102m revenue, or US$3.2m). Market cap is less than US$100m (NT$396.0m market cap, or US$12.2m).
Reported Earnings • Apr 21Full year 2022 earnings released: EPS: NT$0.04 (vs NT$0.72 loss in FY 2021)Full year 2022 results: EPS: NT$0.04 (up from NT$0.72 loss in FY 2021). Revenue: NT$111.2m (flat on FY 2021). Net income: NT$1.53m (up NT$30.4m from FY 2021). Profit margin: 1.4% (up from net loss in FY 2021). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 05Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: NT$0.72 loss per share (down from NT$0.45 loss in FY 2020). Revenue: NT$110.6m (up 29% from FY 2020). Net loss: NT$28.9m (loss widened 62% from FY 2020). Revenue was in line with analyst estimates.
Reported Earnings • Aug 09First half 2021 earnings released: NT$0.46 loss per share (vs NT$0.09 loss in 1H 2020)The company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: NT$55.1m (up 2.2% from 1H 2020). Net loss: NT$18.3m (loss widened 411% from 1H 2020).
Reported Earnings • Apr 02Full year 2020 earnings released: NT$0.45 loss per share (vs NT$0.50 loss in FY 2019)The company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: NT$85.7m (down 15% from FY 2019). Net loss: NT$17.9m (loss narrowed 4.9% from FY 2019).
分析記事 • Mar 25Mortech (GTSM:7419) Is In A Strong Position To Grow Its BusinessEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Is New 90 Day High Low • Jan 27New 90-day low: NT$14.70The company is down 17% from its price of NT$17.70 on 30 October 2020. The Taiwanese market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
分析記事 • Dec 10Companies Like Mortech (GTSM:7419) Can Afford To Invest In GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Is New 90 Day High Low • Oct 29New 90-day low: NT$17.30The company is down 4.0% from its price of NT$18.00 on 31 July 2020. The Taiwanese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period.